Study on the Microbial Environment of Non-small Cell Lung Cancer Based on Mycogenomics and Its Clinical Relevance
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study aims to uncover the characteristics of the fungal flora in non-small cell lung cancer, and to investigate the relationship between pulmonary fungi and the various pathological subtypes, stages, clinical features of non-small cell lung cancer, as well as patient prognosis. It seeks to provide new perspectives for a comprehensive understanding of non-small cell lung cancer, as well as new approaches for its early diagnosis and prognosis assessment.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony rak płuca niezapalny (pobrany wcześniej do badania lub podczas operacji)
- •Wiek od 30 do 80 lat
- •Brak wcześniejszego leczenia chemią, promieniowaniem, terapią celowaną lub immunoterapią
✗ Disqualifies
- •Inny nowotwór złośliwy w ciele lub powrót raka płuca
- •Niedobory odporności
- •Zaostrzenie chorób przewlekłych płuc lub aktywny wrzód płuc
- •Gruźlica lub zapylenie płuc
- •Stosowanie leków przeciwgrzybicznych w ostatnim czasie
- •Brak dostępu do danych o typie nowotworu i stadium choroby
Simplified criteria — AI translation
Trial details
- Minimum age
- 30 Years
- Maximum age
- 80 Years
- Last updated (source)
- August 25, 2026
- Sex
- No restrictions
Locations (1)
958th Army Hospital
Chongqing, China
Trial contact
shunhong wang project leader
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/26/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.